This report provides information on the therapeutic development for Neisseriaceae Infections, complete with latest updates, and special features on late-stage and discontinued projects.
This report provides information on the therapeutic development for Vancomycin-Resistant Enterococcus Faecium Infections, complete with latest updates, and special features on late-stage and discontinued projects.
This report provides information on the therapeutic development for Penile Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Penile Cancer.
This report provides comprehensive information on the therapeutic development for Food Allergy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Food Allergy and special features on late-stage and discontinued projects.
http://www.researchmoz.us/food-allergy-pipeline-review-h1-2015-report.html
Myriad genetics, inc. product pipeline analysisraja1233
Companyprofilesandconferences.com glad to promote a new report on "Myriad Genetics, Inc. (MYGN) - Product Pipeline Analysis" which is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products who provides key information about the company, its major products and brands.
BOC Sciences Updated Its Product Catalog of Pharmaceutical Impurity Reference...BOC Sciences
BOC Sciences recently updated its product list of pharmaceutical impurity reference standards to better serve pharmaceutical companies, scientific research units, testing institutions and universities. Visit https://www.bocsci.com/products/impurities-8.html for more information.
This report provides information on the therapeutic development for Vancomycin-Resistant Enterococcus Faecium Infections, complete with latest updates, and special features on late-stage and discontinued projects.
This report provides information on the therapeutic development for Penile Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Penile Cancer.
This report provides comprehensive information on the therapeutic development for Food Allergy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Food Allergy and special features on late-stage and discontinued projects.
http://www.researchmoz.us/food-allergy-pipeline-review-h1-2015-report.html
Myriad genetics, inc. product pipeline analysisraja1233
Companyprofilesandconferences.com glad to promote a new report on "Myriad Genetics, Inc. (MYGN) - Product Pipeline Analysis" which is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products who provides key information about the company, its major products and brands.
BOC Sciences Updated Its Product Catalog of Pharmaceutical Impurity Reference...BOC Sciences
BOC Sciences recently updated its product list of pharmaceutical impurity reference standards to better serve pharmaceutical companies, scientific research units, testing institutions and universities. Visit https://www.bocsci.com/products/impurities-8.html for more information.
This report provides comprehensive information on the therapeutic development for Respiratory Depression, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Respiratory Depression and special features on late-stage and discontinued projects.
http://www.researchmoz.us/respiratory-depression-pipeline-review-h1-2015-report.html
Cook medical incorporated product pipeline analysisraja1233
Companyprofilesandconferences.com glad to promote a new report on "Cook Medical Incorporated - Product Pipeline Analysis" which is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products also provides key information about the company, its major products and brands.
Companyprofilesandconferences.com glad to promote a new report on "Digna Biotech, S.L. - Product Pipeline Analysis" which are focuses on the development and commercialization of robust clinical therapeutic candidates through partnerships with pharmaceutical companies.
"Pharmaceutical sciences
and the challenge for a healthcare focused agenda for pharmacists training"
(A interface ensino-profissão no desenvolvimento das Ciências Farmacêuticas)
Rogério Gaspar
(Presidente da SPCF)
21.SET.2016
Integra gen s.a (alint) product pipeline analysis, 2014 updateAmbikabasa
Summary IntegraGen S.A (IntegraGen) is a biotechnology service provider. The company provides clinical genomic services to academic researchers and life sciences companies. It offers services such as DNA extraction, management samples, study design, strategy, selection markers, tagging, biostatistics analysis, and bioinformatics analysis of sequence data. IntegraGen provides sequencing and genotyping of DNA and RNA. The company offers services in the fields of pharmacogenetics, cytogenetics, epigenetics, and agriculture. It serves patients, clinicians and researchers. IntegraGen partners with illumia, Fluidigm, DNA genotek and Agitent Certified companies.
http://www.researchmoz.us/integragen-sa-alint-product-pipeline-analysis-2014-update-report.html
Clinical data sharing: why publishing negative and less impactful results is ...Ann-Marie Roche
Clinical data sharing: why publishing negative and less impactful results is important for patient safety
Clinical trials are essential in drug development and are the cornerstone for getting a medicinal product authorized for marketing, because clinical trials investigate efficacy and drug safety. When the results of clinical trials are published, they can be informative to health care professionals, policy makers, media and the general public. But not all trial results are conclusive or significant, and many trials show that drugs are ineffective. These results often do not get published, either because these results are not suitable for a journal or because the researcher does not think these results are worth publishing. Due to the fact that inconclusive and insignificant results are not published, we are facing a publication bias towards positive results. During this webinar the speaker will demonstrate why publishing negative and less impactful results of clinical trials, as in Elsevier’s newly launched Open Access Journal ‘Contemporary Clinical Trials Communications’ reduces publication bias and is important for patient safety.
New technologies and the outsourcing of clinical trials to lower-cost countries will slow the recent annual increases in expenditures in the U.S. to a 3.3% compound annual growth rate (CAGR) over the forecast period.
This report provides comprehensive information on the therapeutic development for Respiratory Depression, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Respiratory Depression and special features on late-stage and discontinued projects.
http://www.researchmoz.us/respiratory-depression-pipeline-review-h1-2015-report.html
Cook medical incorporated product pipeline analysisraja1233
Companyprofilesandconferences.com glad to promote a new report on "Cook Medical Incorporated - Product Pipeline Analysis" which is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products also provides key information about the company, its major products and brands.
Companyprofilesandconferences.com glad to promote a new report on "Digna Biotech, S.L. - Product Pipeline Analysis" which are focuses on the development and commercialization of robust clinical therapeutic candidates through partnerships with pharmaceutical companies.
"Pharmaceutical sciences
and the challenge for a healthcare focused agenda for pharmacists training"
(A interface ensino-profissão no desenvolvimento das Ciências Farmacêuticas)
Rogério Gaspar
(Presidente da SPCF)
21.SET.2016
Integra gen s.a (alint) product pipeline analysis, 2014 updateAmbikabasa
Summary IntegraGen S.A (IntegraGen) is a biotechnology service provider. The company provides clinical genomic services to academic researchers and life sciences companies. It offers services such as DNA extraction, management samples, study design, strategy, selection markers, tagging, biostatistics analysis, and bioinformatics analysis of sequence data. IntegraGen provides sequencing and genotyping of DNA and RNA. The company offers services in the fields of pharmacogenetics, cytogenetics, epigenetics, and agriculture. It serves patients, clinicians and researchers. IntegraGen partners with illumia, Fluidigm, DNA genotek and Agitent Certified companies.
http://www.researchmoz.us/integragen-sa-alint-product-pipeline-analysis-2014-update-report.html
Clinical data sharing: why publishing negative and less impactful results is ...Ann-Marie Roche
Clinical data sharing: why publishing negative and less impactful results is important for patient safety
Clinical trials are essential in drug development and are the cornerstone for getting a medicinal product authorized for marketing, because clinical trials investigate efficacy and drug safety. When the results of clinical trials are published, they can be informative to health care professionals, policy makers, media and the general public. But not all trial results are conclusive or significant, and many trials show that drugs are ineffective. These results often do not get published, either because these results are not suitable for a journal or because the researcher does not think these results are worth publishing. Due to the fact that inconclusive and insignificant results are not published, we are facing a publication bias towards positive results. During this webinar the speaker will demonstrate why publishing negative and less impactful results of clinical trials, as in Elsevier’s newly launched Open Access Journal ‘Contemporary Clinical Trials Communications’ reduces publication bias and is important for patient safety.
New technologies and the outsourcing of clinical trials to lower-cost countries will slow the recent annual increases in expenditures in the U.S. to a 3.3% compound annual growth rate (CAGR) over the forecast period.
This report provides comprehensive information on the therapeutic development for Seborrhea, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Seborrhea and special features on late-stage and discontinued projects.
http://www.researchmoz.us/seborrhea-pipeline-review-h1-2015-report.html
This report provides comprehensive information on the therapeutic development for Emphysema, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Emphysema and special features on late-stage and discontinued projects.
http://www.researchmoz.us/emphysema-pipeline-review-h1-2015-report.html
This report provides comprehensive information on the therapeutic development for Herpes Zoster (Shingles), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Herpes Zoster (Shingles) and special features on late-stage and discontinued projects.
http://www.researchmoz.us/herpes-zoster-shingles-pipeline-review-h1-2015-report.html
This report provides comprehensive information on the therapeutic development for Traveler's Diarrhea, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Traveler's Diarrhea and special features on late-stage and discontinued projects.
http://www.researchmoz.us/travelers-diarrhea-pipeline-review-h1-2015-report.html
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Severe acute respiratory syndrome (sars) coronavirus infection pipeline overv...Rashmi Jawalkar
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Mechanism of action Insights 2017, report provides comprehensive insights of the ongoing therapeutic research and development across Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection
This report provides comprehensive information on the therapeutic development for Raynauds Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Raynauds Disease and special features on late-stage and discontinued projects.
http://www.researchmoz.us/raynauds-disease-pipeline-review-h1-2015-report.html
This report provides comprehensive information on the therapeutic development for Nicotine Addiction, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Nicotine Addiction and special features on late-stage and discontinued projects.
http://www.researchmoz.us/nicotine-addiction-pipeline-review-h1-2015-report.html
Influenza a infections pipeline review, h1 2014Ambikabasa
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
This report provides comprehensive information on the therapeutic development for Ocular Pain, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Ocular Pain and special features on late-stage and discontinued projects.
http://www.researchmoz.us/ocular-pain-pipeline-review-h1-2015-report.html
This report provides comprehensive information on the therapeutic development for H1N1 Infection, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for H1N1 Infection and special features on late-stage and discontinued projects.
http://www.researchmoz.us/h1n1-infection-pipeline-review-h1-2015-report.html
This report provides comprehensive information on the therapeutic development for Diarrhea, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Diarrhea and special features on late-stage and discontinued projects.
http://www.researchmoz.us/diarrhea-pipeline-review-h1-2015-report.html
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
This report provides information on the therapeutic development for Coronary Vasospasm, complete with latest updates, and special features on late-stage and discontinued projects.
This report provides comprehensive information on the therapeutic development for Rhabdomyosarcoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Rhabdomyosarcoma and special features on late-stage and discontinued projects.
http://www.researchmoz.us/rhabdomyosarcoma-pipeline-review-h1-2015-report.html
Market Research Reports, Inc. has announced the addition of “Corneal Graft Rejection - Pipeline Insight, 2018” research report to their offering. See more at - http://mrr.cm/UWg
Commercial considerations in early drug developmentSunil Ramkali
It is important in the drug development process that marketers and researchers collaborate early to ensure that products being developed are truly innovative and deliver brand value to the different end users in a way that the product and the subsequent brand messaging is relevant, compelling and differentiating compared to the competition. T
In the market place that is heavily cost constraint, innovation is no longer about a unique mode of action or a new formulation, but more about the incremental brand value offered by new pharmaceutical products over existing treatments (standard of care) and how much healthcare systems are prepared to pay for these incremental benefits. My lecture at the Department of Innovation, Lund University, Sweden explored the importance of R&D functions getter closer to external stakeholders to really understand their needs, how they define brand value and the importance of considering this early in the drug development process.
Market Research Reports, Inc. has announced the addition of “Vulvar Cancer - Pipeline Insight, 2018” research report to their offering. See more at - http://mrr.cm/UBP
Similar to Neisseriaceae infections pipeline review, q3 2011 (20)
In 2012, the global tire market size approximated USD185.8 billion, up 2.6% from a year earlier. The estimation shows that the growth rate in 2013 will be no more than 0.5%.
US demand for roofing is forecast to rise 5.7 percent per year to 263 million squares in 2015, valued at $24.4 billion. This pace represents a turnaround from the 6.1 percent annual declines experienced between 2005 and 2010. Advances will be driven by the rebound in building construction expenditures from their depressed 2010 base.
This Euromonitor market report provides market trend and market growth analysis of the Home Care industry in Pakistan. With this market report, you’ll be able to explore in detail the changing shape and potential of the industry. You will now be able to plan and build strategy on real industry data and projections.
This Euromonitor market report provides market trend and market growth analysis of the Apparel industry in Germany. With this market report, you’ll be able to explore in detail the changing shape and potential of the industry. You will now be able to plan and build strategy on real industry data and projections.
Product profiles alzheimer's disease immunotherapies can revolutionize trea...linda3395
The beta-amyloid hypothesis has so far failed to deliver a viable candidate, contributing to an absence of new market entrants over the past decade. However, given the weight of candidates with disease-modifying potential in the pipeline, new drugs are expected to emerge that will satisfy one of the biggest unmet needs in the industry – a treatment that slows Alzheimer’s disease neurodegeneration.Market Research Reports, Market Research, Industry Analysis, Market Share, Market Size, marketing research,
Pharmaceutical Market Research,Pharmaceutical Market Research Reports,Pharmaceuticals Market Research,Pharmaceuticals Market Research Reports
As of late September 2011, the relatively few statistics available suggest that non-life premiums contracted in H111, having (probably) shrunk in calendar 2010. Conditions for non-life insurers were far from optimal even before the political unrest in Bahrain earlier this year.
Demand for converted flexible packaging in the US is expected to exceed $18 billion in 2015. Gains will reflect a rebound in the US economy and will be supported by cost, performance and source reduction advantages over most rigid packaging formats.
Demand for biologics will exceed $100 billion in 2015, experiencing continuing strong growth following a decade of double-digit annual increases. Continued growth will be driven by dramatic shifts in production technology and expansion of targeted diseases, and challenged by the introduction of biosimilar products following patent expiry of major biologic products.
The netherlands interior products industry, key trends and opportunitieslinda3395
This report will help you to understand manufacturing, trade, retail and demand-side dynamics within Dutch interior products market highlighting key market trends and growth opportunities
The future of interior products in poland to 2015linda3395
The report provides an indispensable source of market size, distribution and end-user segmentation analysis covering Polish interior products industry.
Nanotechnology a realistic market assessmentlinda3395
This report provide investors and others with information on the commercial potential of various nanotechnologies and to complement the growing body of technical information
Esophageal cancer pipeline review, q3 2011linda3395
This report provides information on the therapeutic development for Esophageal Cancer, complete with latest updates, and special features on late-stage and discontinued projects.
The future of interior products in germany to 2015 demand to gather pace from...linda3395
The report provides an indispensable source of market size, distribution and end-user segmentation analysis covering German interior products industry.
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
Best Ayurvedic medicine for Gas and IndigestionSwastikAyurveda
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Neisseriaceae infections pipeline review, q3 2011
1. Neisseriaceae Infections - Pipeline Review, Q3 2011
Summary
Global Markets Direct’s, 'Neisseriaceae Infections - Pipeline Review, Q3 2011',
provides an overview of the Neisseriaceae Infections therapeutic pipeline. This
report provides information on the therapeutic development for Neisseriaceae
Infections, complete with latest updates, and special features on late-stage and
discontinued projects. It also reviews key players involved in the therapeutic
development for Neisseriaceae Infections. 'Neisseriaceae Infections - Pipeline
Review, Q3 2011' is built using data and information sourced from Global Markets
Direct’s proprietary databases, Company/University websites, SEC filings, investor
presentations and featured press releases from company/university sites and
industry-specific third party sources, put together by Global Markets Direct’s team.
Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.
Scope
- A snapshot of the global therapeutic scenario for Neisseriaceae Infections.
- A review of the Neisseriaceae Infections products under development by
companies and universities/research institutes based on information derived from
company and industry-specific sources.
- Coverage of products based on various stages of development ranging from
discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined
therapeutics.
- Coverage of the Neisseriaceae Infections pipeline on the basis of therapeutic
class, route of administration and molecule type.
- Profiles of late-stage pipeline products featuring sections on product description,
mechanism of action and research & development progress.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Browse All Pharmaceuticals Market Research Reports
Reasons to buy
- Identify and understand important and diverse types of therapeutics under
development for Neisseriaceae Infections.
- Identify emerging players with potentially strong product portfolio and design
effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players with the most
promising pipeline.
- Devise corrective measures for pipeline projects by understanding Neisseriaceae
2. Infections pipeline depth and focus of Neisseriaceae Infections therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying
prospective partners with the most attractive projects to enhance and expand
business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and
understanding the factors that drove them from pipeline.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Neisseriaceae Infections Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for Neisseriaceae Infections 7
Neisseriaceae Infections Therapeutics under Development by Companies 9
Late Stage Products 10
Comparative Analysis 10
Mid Clinical Stage Products 11
Comparative Analysis 11
Pre-Clinical Stage Products 12
Comparative Analysis 12
Neisseriaceae Infections Therapeutics - Products under Development by Companies
13
Companies Involved in Neisseriaceae Infections Therapeutics Development 14
GlaxoSmithKline plc 14
Kenta Biotech Ltd. 14
Endo Pharmaceuticals Inc. 15
Neisseriaceae Infections - Therapeutics Assessment 16
Assessment by Monotherapy Products 16
Assessment by Route of Administration 17
Assessment by Molecule Type 19
Drug Profiles 21
PRO 2000/5 Gel - Drug Profile 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
KBAB401 - Drug Profile 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Heptavalent Combination Vaccine - Drug Profile 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
3. Hexavalent Combination Vaccine - Drug Profile 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
Neisseriaceae Infections Therapeutics – Drug Profile Updates 25
Neisseriaceae Infections - Featured News 26
Sep 12, 2010: Novartis Phase III Study Shows Meningococcal B Vaccine Candidate
Could Be First To Provide Broad Coverage Against Deadly Disease 26
Sep 12, 2010: Novartis Presents Phase III Study Results On Multicomponent
Meningococcal Serogroup B Vaccine At International Pathogenic Neisseria
Conference 27
Appendix 29
Methodology 29
Coverage 29
Secondary Research 29
Primary Research 29
Expert Panel Validation 30
Contact Us 30
Disclaimer 30
About Us:
ReportsnReports is an online library of over 100,000+ market research reports and
in-depth market research studies & analysis of over 5000 micro markets. We
provide 24/7 online and offline support to our customers. Get in touch with us for
your needs of market research reports.
Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page:
http://www.facebook.com/pages/ReportsnReports/191441427571689
Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: +1-888-989-8004
E-mail: sales@reportsandreports.com
http://www.reportsandreports.com
Visit our Market Research Blog